secwatch.observer — SEC 8-K summary
======================================

Issuer:     Marker Therapeutics, Inc. (MRKR)
CIK:        0001094038
Form:       8-K
Filed at:   2023-01-26T23:59:59+00:00
Accession:  0001104659-23-007019
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Marker Therapeutics files amendment for 1-for-10 reverse stock split and authorized share reduction
--------------------------------------------------------------------------------

- Filed Certificate of Amendment on January 26, 2023, effective 5:00 p.m. ET that day.
- Reverse stock split combines every 10 shares into 1, with no fractional shares issued.
- Authorized shares reduced from 300,000,000 to 30,000,000 at same par value of $0.001.
- Common stock will begin trading on Nasdaq Capital Market on a split-adjusted basis on January 27, 2023.
- Adjustments made to all outstanding stock options, warrants, and equity compensation reserves.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1094038/000110465923007019/0001104659-23-007019-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1094038/000110465923007019/tm234466d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-007019

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer